gallium-ga-68-dotatate and Inflammation

gallium-ga-68-dotatate has been researched along with Inflammation* in 5 studies

Other Studies

5 other study(ies) available for gallium-ga-68-dotatate and Inflammation

ArticleYear
    Journal of the American College of Cardiology, 2019, 05-21, Volume: 73, Issue:19

    Topics: Bone Marrow; Echocardiography; Gallium Radioisotopes; Humans; Inflammation; Myocardial Infarction; Organometallic Compounds; Percutaneous Coronary Intervention; Positron-Emission Tomography; Radiopharmaceuticals; Wound Healing

2019
Imaging Vulnerable Plaque: A Medical Necessity or a Scientific Curiosity?
    Journal of the American College of Cardiology, 2017, 04-11, Volume: 69, Issue:14

    Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Organometallic Compounds; Plaque, Atherosclerotic; Positron-Emission Tomography

2017
Somatostatin receptor-positive granulomatous inflammation mimicking as meningioma on simultaneous PET/MRI.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:1

    Positron imaging with radiolabeled synthetic somatostatin receptor analogs such as Ga DOTATATE (Gallium-68-1,4,7,10-tetraazacyclododecane-N,N',N″,N‴-tetra acetic acid-DPhe1,Tyr3-octreotate) is used for diagnosis and target volume delineation of intracranial meningiomas. We report a case of a somatostatin receptor-positive extra-axial necrotizing granulomatous inflammation mimicking as meningioma on simultaneous Ga DOTATATE PET/MRI. This case illustrates a Ga DOTATATE-positive granuloma bearing a striking resemblance to meningioma.

    Topics: Aged; Diagnosis, Differential; Female; Granuloma; Humans; Inflammation; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Multimodal Imaging; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin

2015
Targeting post-infarct inflammation by PET imaging: comparison of (68)Ga-citrate and (68)Ga-DOTATATE with (18)F-FDG in a mouse model.
    European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:2

    Imaging of inflammation early after myocardial infarction (MI) is a promising approach to the guidance of novel molecular interventions that support endogenous healing processes. (18)F-FDG PET has been used, but may be complicated by physiological myocyte uptake. We evaluated the potential of two alternative imaging targets: lactoferrin binding by (68)Ga-citrate and somatostatin receptor binding by (68)Ga-DOTATATE.. C57Bl/6 mice underwent permanent coronary artery ligation. Serial PET imaging was performed 3 - 7 days after MI using (68)Ga-citrate, (68)Ga-DOTATATE, or (18)F-FDG with ketamine/xylazine suppression of myocyte glucose uptake. Myocardial perfusion was evaluated by (13)N-ammonia PET and cardiac geometry by contrast-enhanced ECG-gated CT.. Mice exhibited a perfusion defect of 30 - 40% (of the total left ventricle) with apical anterolateral wall akinesia and thinning on day 7 after MI. (18)F-FDG with ketamine/xylazine suppression demonstrated distinct uptake in the infarct region, as well as in the border zone and remote myocardium. The myocardial standardized uptake value in MI mice was significantly higher than in healthy mice under ketamine/xylazine anaesthesia (1.9 ± 0.4 vs. 1.0 ± 0.1). (68)Ga images exhibited high blood pool activity with no specific myocardial uptake up to 90 min after injection (tissue-to-blood contrast 0.9). (68)Ga-DOTATATE was rapidly cleared from the blood, but myocardial SUV was very low (0.10 ± 0.03).. Neither (68)Ga nor (68)Ga-DOTATATE is a useful alternative to (18)F-FDG for PET imaging of myocardial inflammation after MI in mice. Among the three tested approaches, (18)F-FDG with ketamine/xylazine suppression of cardiomyocyte uptake remains the most practical imaging marker of post-infarct inflammation.

    Topics: Animals; Citrates; Fluorodeoxyglucose F18; Gallium; Inflammation; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Perfusion Imaging; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals

2015
Peptide receptor-targeted radionuclide therapy alters inflammation in atherosclerotic plaques.
    Journal of the American College of Cardiology, 2013, Dec-17, Volume: 62, Issue:24

    Topics: Female; Humans; Hypercholesterolemia; Inflammation; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Organometallic Compounds; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Receptors, Somatostatin; Retrospective Studies; Tomography, X-Ray Computed

2013